FDA Limits Johnson & Johnson's COVID Vaccine
The U.S. Food and Drug Administration is limiting the use of Johnson & Johnson's (J&J)COVID-19 vaccine. Though the potential benefits of the vaccine outweigh the risks, the FDA said last week that it is restricting the use of the J&J vaccine. It will be limited to individuals 18 and older and medically ineligible for another approved vaccine and to those who only have access to the J&J vaccine and want one, according to an FDA news release. Researchers with the FDA and Centers for Disease Control and Prevention found that the vaccine resulted in 60 confirmed cases of thrombosis with thrombocytopenia syndrome.